New Management At Theradex Oncology

February 2020

Top recruits from biotech and healthcare join Theradex Oncology
Theradex Oncology, a clinical research organization specializing in cancer drug development, announced today that Dawn Stephenson has been appointed Regulatory Affairs Director at Theradex Oncology and Dr. Farheen Ahmed has joined the clinical team as Head of Pharmacovigilance, both appointments will strengthen the company's European and international operations.

Top recruits from biotech and healthcare join Theradex Oncology